Use of a Hypertension Tool to Manage Blood Pressure in Hemodialysis
Primary Purpose
Hypertension
Status
Completed
Phase
Not Applicable
Locations
Canada
Study Type
Interventional
Intervention
Hypertension tool
Sponsored by

About this trial
This is an interventional treatment trial for Hypertension
Eligibility Criteria
Inclusion Criteria:
- ≥ 18 years of age
- Receiving in-centre HD for at least 3 months
- Considered hypertensive based on a median intradialytic blood pressure ≥ 140/90 mmgHG
Exclusion Criteria:
- Are unable to provide informed consent
- Are deemed medically unstable by the primary physician
Sites / Locations
- Toronto General Hospital
Arms of the Study
Arm 1
Arm 2
Arm Type
Experimental
No Intervention
Arm Label
Implementation group
Control group
Arm Description
This group will have the hypertension tool implemented on them.
This group will not have the tool implemented.
Outcomes
Primary Outcome Measures
Blood pressure
Secondary Outcome Measures
Full Information
NCT ID
NCT03089385
First Posted
March 20, 2017
Last Updated
April 30, 2021
Sponsor
University Health Network, Toronto
1. Study Identification
Unique Protocol Identification Number
NCT03089385
Brief Title
Use of a Hypertension Tool to Manage Blood Pressure in Hemodialysis
Official Title
Development, Validation, and Implementation of a Clinical Decision Tool for Blood Pressure Management in Patients on Hemodialysis
Study Type
Interventional
2. Study Status
Record Verification Date
April 2021
Overall Recruitment Status
Completed
Study Start Date
February 22, 2016 (Actual)
Primary Completion Date
April 9, 2021 (Actual)
Study Completion Date
April 9, 2021 (Actual)
3. Sponsor/Collaborators
Responsible Party, by Official Title
Sponsor
Name of the Sponsor
University Health Network, Toronto
4. Oversight
Studies a U.S. FDA-regulated Drug Product
No
Studies a U.S. FDA-regulated Device Product
No
5. Study Description
Brief Summary
The objective of this project is to develop, validate, and implement a tool to help manager hypertension in patients on hemodialysis.
6. Conditions and Keywords
Primary Disease or Condition Being Studied in the Trial, or the Focus of the Study
Hypertension
7. Study Design
Primary Purpose
Treatment
Study Phase
Not Applicable
Interventional Study Model
Single Group Assignment
Masking
None (Open Label)
Allocation
Non-Randomized
Enrollment
38 (Actual)
8. Arms, Groups, and Interventions
Arm Title
Implementation group
Arm Type
Experimental
Arm Description
This group will have the hypertension tool implemented on them.
Arm Title
Control group
Arm Type
No Intervention
Arm Description
This group will not have the tool implemented.
Intervention Type
Other
Intervention Name(s)
Hypertension tool
Intervention Description
An algorithm developed by staff at UHN to help manage hypertension in hemodialysis patients.
Primary Outcome Measure Information:
Title
Blood pressure
Time Frame
3 months
10. Eligibility
Sex
All
Accepts Healthy Volunteers
Accepts Healthy Volunteers
Eligibility Criteria
Inclusion Criteria:
≥ 18 years of age
Receiving in-centre HD for at least 3 months
Considered hypertensive based on a median intradialytic blood pressure ≥ 140/90 mmgHG
Exclusion Criteria:
Are unable to provide informed consent
Are deemed medically unstable by the primary physician
Overall Study Officials:
First Name & Middle Initial & Last Name & Degree
Marisa Battistella
Organizational Affiliation
University Health Network, Toronto
Official's Role
Principal Investigator
Facility Information:
Facility Name
Toronto General Hospital
City
Toronto
State/Province
Ontario
Country
Canada
12. IPD Sharing Statement
Learn more about this trial
Use of a Hypertension Tool to Manage Blood Pressure in Hemodialysis
We'll reach out to this number within 24 hrs